New pill shows promise in keeping Tourette's tics at bay
Disease control
Completed
This study tested whether a medication called ecopipam could safely maintain its benefits for people with Tourette's Disorder after they initially responded to it. It involved 216 children, teens, and adults. First, everyone took the drug for 12 weeks. Those who improved were the…
Phase: PHASE3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC